1Leclercq R, Derlot E, Dural J, et al. Plasmid-mediated resistance to Vancomycin and Teicoplanin in Enterococcusfaecium[J] .N Engl J Med, 1988, 319(7): 157 - 160.
2Uttley AH, Collins CH, Naidoo J. et al. Vancomycinresistant enterococci [J]. Lancet, 1993,342(4): 615.
3Aksoy DY, Tanriover MD, Unal S. Antimicrobial resistance: preventable of inevitable. Problem of the era from two perspectives[C]//Gould IM, van der Meet JWM. Antibiotic policies: fighting resistance. New York: Springer, Septemberus, 2007:113 - 133.
5Cocito C, Di Giambattista M, Nyssen E, et al. Inhibition of protein synthesis by streptogramins and related antibiotics[J]. Antimicrob Chemother, 1997,39(suppl A): 7 - 13.
6Maclayton DO, Hall RG. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus[J]. Ann Pharmacother, 2007, 41 (2) : 235 - 244.
7Nichols RL, Graham DR, Barriere SL, et al. Treatment of hospitalized patients with complicated gram- positive skin and skin structure infections: two randomized, muhicentre studies of quinupristin-dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group[J]. Antimicrob Chemother, 1999,44(2): 263 -273.
8Moeilering RC, Linden PK, Reinhardt J, et al. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group[J]. Antimicrob Chemother, 1999, 44(2) : 251 - 261.
9Stamatakis MK, Richards JG. Interaction between quinupristin/dalfopristin and cyclosporine[J]. Ann Pbarmacother, 1997, 31 (5): 576 -578.
4TEDESCO K L, RYBAK M J. Daptomycin [ J ]. Pharmacotherapy,2004,24( 1 ) :41-57.
5WEHBE J, ROLLAND V, ROUMESTANT M L, et al. Glutamate transporter blockers enantiomerically pure(2S, 3 S ) -and ( 2R, 3R) -3-methyl glutamic acids [ J ]. Tetrahed. ron :Asymmetry,2003,14(9) : 1 123-1 126.
6HERDEIS C, KELM B. A stereoseletive synthesis of 3- substituted (S)-pyroglutamic and glutamic acids via OBO ester derivatives [ J ]. Tetrahedron, 2003,59 ( 2 ) : 217-229.
7OBA M ,SAEQUSA T,NISHIYA N. Synthesis of non-proteinogenic amino acids using Michael addition to unsaturated orthopyroglutamate derivative [ J ]. Tetrahedron, 2009,65(1) :128-133.
8BELOKON Y N. (S)-2-[ N-(N'-Benzylprolyl) amino] benzopheone ( BPB ) -a reagent for the synthesis of optically pure a-amino acids [ J ]. Jassen Chim. Acta, 1992, 10 (2) :4-12.
9BELOKON Y N,KOCHETKOV K A,CHURKINA T D, et al. The first example of asymmetric Michael reaction catalyzed by ehiral alkali metal alkoxides [ J ]. Rus. Chem. Bull. , 1998,47 ( 1 ) : 74-81.
10SOLOSHONOK V A, CAI Chao-zhong, HRUBY V J. Asymmetric Michael addition reactions of chiral Ni ( II ) -complex of glycine with ( N-trans-enoyl ) oxazolidines: improved reactivity and stereochemical outcome [ J ]. Tetrahedron : Asymmetry, 1999, 10 ( 22 ) : 4 265- 4 269.
